NO970089D0 - Sulfonamidazolonderivater med anti-Helicobacteraktivitet - Google Patents
Sulfonamidazolonderivater med anti-HelicobacteraktivitetInfo
- Publication number
- NO970089D0 NO970089D0 NO970089A NO970089A NO970089D0 NO 970089 D0 NO970089 D0 NO 970089D0 NO 970089 A NO970089 A NO 970089A NO 970089 A NO970089 A NO 970089A NO 970089 D0 NO970089 D0 NO 970089D0
- Authority
- NO
- Norway
- Prior art keywords
- image
- 4alkyl
- compounds
- sulfonamidazolone
- derivatives
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 abstract 1
- -1 C1-4alkyloxy Chemical group 0.000 abstract 1
- 206010019375 Helicobacter infections Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Lubricants (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94202015 | 1994-07-12 | ||
| PCT/EP1995/002619 WO1996001818A1 (en) | 1994-07-12 | 1995-07-05 | Sulfonamide derivatives of azolones anti-helicobacter agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO970089D0 true NO970089D0 (no) | 1997-01-09 |
| NO970089L NO970089L (no) | 1997-03-10 |
Family
ID=8217029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970089A NO970089L (no) | 1994-07-12 | 1997-01-09 | Sulfonamidazolonderivater med anti-Helicobacteraktivitet |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5571811A (no) |
| EP (1) | EP0770071B1 (no) |
| JP (1) | JPH10502386A (no) |
| CN (1) | CN1068878C (no) |
| AT (1) | ATE206706T1 (no) |
| AU (1) | AU684981B2 (no) |
| BR (1) | BR9508376A (no) |
| CA (1) | CA2194562A1 (no) |
| CZ (1) | CZ2997A3 (no) |
| DE (1) | DE69523159T2 (no) |
| FI (1) | FI970113A0 (no) |
| HU (1) | HUT76636A (no) |
| IL (1) | IL114537A (no) |
| MX (1) | MX9700340A (no) |
| NO (1) | NO970089L (no) |
| NZ (1) | NZ289853A (no) |
| PL (1) | PL318149A1 (no) |
| SK (1) | SK4497A3 (no) |
| TW (1) | TW341571B (no) |
| WO (1) | WO1996001818A1 (no) |
| ZA (1) | ZA955760B (no) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571811A (en) * | 1994-07-12 | 1996-11-05 | Janssen Pharmaceutica N.V. | Sulfonamide derivatives of azolones |
| US5639754A (en) * | 1994-07-12 | 1997-06-17 | Janssen Pharmaceutica N.V. | Urea and thiourea derivatives of azolones |
| US5637592A (en) * | 1994-07-12 | 1997-06-10 | Janssen Pharmaceutica N.V. | Acyl derivatives of azolones |
| EP1170013B1 (en) | 1999-03-17 | 2007-01-17 | MORINAGA & CO. LTD. | Drugs, foods, drinks and feeds containing cocoa component |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6780880B1 (en) * | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| DK1563061T3 (da) * | 2002-11-14 | 2012-10-01 | Aderans Res Inst Inc | Dyrkning af hårinducerende celler |
| WO2004083235A2 (en) * | 2003-03-19 | 2004-09-30 | Exelixis Inc. | Tie-2 modulators and methods of use |
| US7829712B2 (en) | 2004-09-20 | 2010-11-09 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
| BRPI0515477A (pt) * | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos bicìclicos e o uso dos mesmos como inibidores de estaroil-coa-desaturase (scd) |
| CN101083994A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途 |
| WO2006034315A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| WO2006034338A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| BRPI0515482A (pt) * | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seus usos como agentes terapêuticos |
| BRPI0515488A (pt) * | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados de heterocìclicos e seu uso como agentes terapêuticos |
| EP1827438B2 (en) * | 2004-09-20 | 2014-12-10 | Xenon Pharmaceuticals Inc. | Piperazin derivatives for inhibiting human stearoyl-coa-desaturase |
| TW200624427A (en) * | 2004-09-20 | 2006-07-16 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| BRPI0611187A2 (pt) * | 2005-06-03 | 2010-08-24 | Xenon Pharmaceuticals Inc | derivados aminotiazàis como inibidores da estearoil-coa desaturase humana |
| US20220122691A1 (en) * | 2019-01-06 | 2022-04-21 | Psomagen Inc. | HtrA Inhibitors and CagA Inhibitors and Use Thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| CA2076257A1 (en) * | 1991-09-13 | 1993-03-14 | Jan Heeres | 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
| US5571811A (en) * | 1994-07-12 | 1996-11-05 | Janssen Pharmaceutica N.V. | Sulfonamide derivatives of azolones |
-
1995
- 1995-05-23 US US08/447,505 patent/US5571811A/en not_active Expired - Fee Related
- 1995-05-25 TW TW084105259A patent/TW341571B/zh active
- 1995-07-05 AU AU29819/95A patent/AU684981B2/en not_active Ceased
- 1995-07-05 CZ CZ9729A patent/CZ2997A3/cs unknown
- 1995-07-05 HU HU9700080A patent/HUT76636A/hu unknown
- 1995-07-05 PL PL95318149A patent/PL318149A1/xx unknown
- 1995-07-05 BR BR9508376A patent/BR9508376A/pt unknown
- 1995-07-05 CN CN95194022A patent/CN1068878C/zh not_active Expired - Fee Related
- 1995-07-05 CA CA002194562A patent/CA2194562A1/en not_active Abandoned
- 1995-07-05 WO PCT/EP1995/002619 patent/WO1996001818A1/en active IP Right Grant
- 1995-07-05 SK SK44-97A patent/SK4497A3/sk unknown
- 1995-07-05 DE DE69523159T patent/DE69523159T2/de not_active Expired - Fee Related
- 1995-07-05 EP EP95925838A patent/EP0770071B1/en not_active Expired - Lifetime
- 1995-07-05 MX MX9700340A patent/MX9700340A/es unknown
- 1995-07-05 JP JP8504112A patent/JPH10502386A/ja active Pending
- 1995-07-05 US US08/776,003 patent/US5728700A/en not_active Expired - Fee Related
- 1995-07-05 AT AT95925838T patent/ATE206706T1/de not_active IP Right Cessation
- 1995-07-11 ZA ZA955760A patent/ZA955760B/xx unknown
- 1995-07-11 IL IL11453795A patent/IL114537A/xx active IP Right Grant
-
1997
- 1997-01-08 NZ NZ289853A patent/NZ289853A/en unknown
- 1997-01-09 NO NO970089A patent/NO970089L/no not_active Application Discontinuation
- 1997-01-10 FI FI970113A patent/FI970113A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA955760B (en) | 1997-01-13 |
| IL114537A (en) | 1999-04-11 |
| IL114537A0 (en) | 1995-11-27 |
| CA2194562A1 (en) | 1996-01-25 |
| HUT76636A (en) | 1997-10-28 |
| FI970113A (fi) | 1997-01-10 |
| EP0770071B1 (en) | 2001-10-10 |
| AU2981995A (en) | 1996-02-09 |
| TW341571B (en) | 1998-10-01 |
| PL318149A1 (en) | 1997-05-12 |
| DE69523159D1 (de) | 2001-11-15 |
| FI970113A0 (fi) | 1997-01-10 |
| SK4497A3 (en) | 1997-12-10 |
| US5571811A (en) | 1996-11-05 |
| AU684981B2 (en) | 1998-01-08 |
| DE69523159T2 (de) | 2002-06-20 |
| CZ2997A3 (en) | 1997-09-17 |
| NZ289853A (en) | 1997-11-24 |
| EP0770071A1 (en) | 1997-05-02 |
| ATE206706T1 (de) | 2001-10-15 |
| NO970089L (no) | 1997-03-10 |
| MX9700340A (es) | 1997-05-31 |
| CN1068878C (zh) | 2001-07-25 |
| JPH10502386A (ja) | 1998-03-03 |
| US5728700A (en) | 1998-03-17 |
| HU9700080D0 (en) | 1997-02-28 |
| CN1152308A (zh) | 1997-06-18 |
| BR9508376A (pt) | 1997-10-28 |
| WO1996001818A1 (en) | 1996-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO970089D0 (no) | Sulfonamidazolonderivater med anti-Helicobacteraktivitet | |
| MX9700339A (es) | Derivados de azolona anti-helcobacter que contienen urea y tiourea. | |
| MX9700342A (es) | Derivados acilicos de azolonas anti-helicobacter. | |
| ES2080297T3 (es) | Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos. | |
| IL67812A (en) | Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same | |
| MX9700338A (es) | Derivados heterociclicos de azolona anti-helicobacter. | |
| DE69523581D1 (de) | Anti-helicobacter ester- oder carbamatderivate von azolonen | |
| SE8105689L (sv) | Terapeutiska medel | |
| BG103271A (en) | Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means | |
| TW429147B (en) | Pharmaceutical composition for the treatment of CNS disorders | |
| MY118312A (en) | Angiogenesis inhibiting 5- substituted- 1,2,4- thiadiazolyl derivatives | |
| DK0622372T3 (da) | Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse | |
| BG50776A1 (en) | Derivatives of n- (2- phenylmorpholinomethyl)- succinamide and method for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |